Nicotine Salt Formulations for Parkinson's Fall Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Individuals with neurodegenerative disorders, particularly Parkinson's disease, experience frequent falls and impaired postural stability due to impaired locomotion and balance, which are not effectively addressed by current dopaminergic treatments, leading to fall-related complications and reduced quality of life.
Innovation Solution
Administering nicotine or its salts in controlled doses, formulated for immediate and delayed release, to reduce fall frequency, improve postural stability, and mitigate levodopa-induced dyskinesias, using various administration methods such as oral, topical, or transdermal delivery, without causing tolerance or dependence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If dopaminergic treatments are administered to improve locomotion and balance in Parkinson's disease, then motor symptoms are temporarily relieved, but fall frequency and postural instability are not effectively addressed and may worsen over time
Solution Approach 1:
The patent segments the treatment approach by introducing a second therapeutic agent (nicotine or nicotinic receptor modulator) that targets a different mechanism (cholinergic system) alongside dopaminergic treatment. This segmentation allows addressing fall and postural instability independently from general motor symptom management, overcoming the limitation where dopaminergic agents fail to prevent falls despite improving locomotion.
Solution Approach 2:
The patent introduces nicotine/nicotinic receptor modulators as an intermediary substance that mediates the cholinergic-dopaminergic interaction. This intermediary targets alpha7 nicotinic acetylcholine receptors to reduce fall frequency and postural instability, providing a bridging mechanism between the two neurotransmitter systems and addressing the gap left by dopaminergic monotherapy.
2Ease of operation
If higher doses of dopaminergic agents are administered to improve motor function, then locomotion and balance are enhanced, but levodopa-induced dyskinesias and fall risk increase
Solution Approach 1:
The patent converts the harmful effect of dopaminergic treatment (increased fall risk and dyskinesias at higher doses) into a benefit by introducing nicotine/nicotinic modulators that specifically counteract these adverse effects. The cholinergic system activation offsets the harmful overstimulation of dopaminergic pathways, transforming the dose-dependent harm into a manageable side effect that can be compensated by the second agent.
Solution Approach 2:
The patent applies preliminary anti-action by using nicotine/nicotinic receptor modulators to preemptively counteract the harmful effects of dopaminergic agents before they manifest as dyskinesias or falls. The cholinergic stimulation serves as a preventive measure that anticipates and offsets the adverse effects of dopaminergic overstimulation.
3Productivity
If current standard treatments are used to manage Parkinson's disease symptoms, then motor symptoms are controlled, but quality of life is reduced due to frequent falls and postural instability
Solution Approach 1:
The patent applies universality by making the nicotine/nicotinic modulator treatment multi-functional: it simultaneously addresses fall frequency, postural instability, and quality of life improvement while working alongside existing dopaminergic therapies. This single agent provides multiple benefits that current standard treatments fail to deliver collectively.
Data Source
AI summary
The present disclosure provides methods and compositions for treating fall-related symptoms in patients with neurodegenerative diseases such as Parkinson's disease or Parkinson-related diseases. In some embodiments, the disclosure utilizes nicotine or a salt thereof in combination of dopaminergic agent treatments for reducing fall-related symptoms such as reducing frequency of fall, reducing injuries related to fall, reducing severity of injuries related to fall, freezing of gait, improving posture stability, improving locomotion ability, improving balance and gait. In some embodiments, the methods predict fall frequency and tendency of recurrent falls in patients with Parkinson's disease, in particular, patients with typical Parkinson's disease.